US Covid-19: US FDA set to authorise Pfizer and Merk Covid-19 pills this week
|The US Food and Drug Administration is poised to authorise Covid-19 pills from Pfizer and Merck this week, tweeted a Bloomberg reporter on Tuesday. According to Pfizer, their pill reduced Covid-19 hospitalization or death by 89% if taken within 3 days of symptom onset. The Merck pill isn't quite as effective but is still thought to reduce mortality by about 50%.
Market Reaction
There hasn't been much of a market reaction to the news, though the pills are very welcome in the fight against the pandemic and, from here out, are expected to reduce US mortality rates.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.